Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+11.76%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$56.8B
AUM Growth
+$7.38B
(+15%)
Cap. Flow
+$2.83B
Cap. Flow
% of AUM
4.98%
Top 10 Holdings %
Top 10 Hldgs %
27.76%
Holding
1,604
New
60
Increased
723
Reduced
255
Closed
38
Top Buys
| 1 |
Procter & Gamble
PG
|
+$205M |
| 2 |
Philip Morris
PM
|
+$203M |
| 3 |
Microsoft
MSFT
|
+$198M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$158M |
| 5 |
Coca-Cola
KO
|
+$144M |
Top Sells
| 1 |
PayPal
PYPL
|
+$223M |
| 2 |
Accenture
ACN
|
+$179M |
| 3 |
Adobe
ADBE
|
+$148M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$64M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$62.7M |
Sector Composition
| 1 | Technology | 29.07% |
| 2 | Healthcare | 15.55% |
| 3 | Financials | 13.39% |
| 4 | Consumer Discretionary | 8.7% |
| 5 | Consumer Staples | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
IPG Photonics
IPGP
$3.44B
| $364K | ﹤0.01% |
3,518
+269
| +8% | +$27.8K |
|
|
FPI
952
Farmland Partners
FPI
$471M
| $363K | ﹤0.01% |
30,029
| – | – |
|
953
Vontier
VNT
$6.29B
| $357K | ﹤0.01% |
10,659
| – | – |
|
954
Iovance Biotherapeutics
IOVA
$861M
| $354K | ﹤0.01% |
44,765
+7,277
| +19% | +$57.5K |
|
955
Weibo
WB
$2.98B
| $351K | ﹤0.01% |
33,274
| – | – |
|
956
Smith & Nephew
SNN
$16.5B
| $344K | ﹤0.01% |
13,022
+1,745
| +15% | +$46.1K |
|
|
WSR
957
Whitestone REIT
WSR
$656M
| $343K | ﹤0.01% |
28,730
| – | – |
|
958
OmniAb
OABI
$226M
| $341K | ﹤0.01% |
54,372
-20,319
| -27% | -$127K |
|
|
LEV
959
DELISTED
The Lion Electric Company
LEV
| $335K | ﹤0.01% |
193,902
-57,033
| -23% | -$98.7K |
|
960
CONMED
CNMD
$1.63B
| $335K | ﹤0.01% |
3,090
+40
| +1% | +$4.33K |
|
|
CLDT
961
Chatham Lodging
CLDT
$349M
| $333K | ﹤0.01% |
31,108
| – | – |
|
|
BFS
962
Saul Centers
BFS
$779M
| $330K | ﹤0.01% |
8,452
| – | – |
|
|
GOOD
963
Gladstone Commercial Corp
GOOD
$598M
| $329K | ﹤0.01% |
25,210
| – | – |
|
|
UHT
964
Universal Health Realty Income Trust
UHT
$569M
| $328K | ﹤0.01% |
7,711
| – | – |
|
965
Rocket Pharmaceuticals
RCKT
$343M
| $327K | ﹤0.01% |
11,390
-2,087
| -15% | -$59.9K |
|
966
Twist Bioscience
TWST
$1.46B
| $323K | ﹤0.01% |
9,934
-12,105
| -55% | -$394K |
|
967
Lufax Holding
LU
$2.54B
| $320K | ﹤0.01% |
112,919
-20,293
| -15% | -$57.4K |
|
968
Arcturus Therapeutics
ARCT
$489M
| $316K | ﹤0.01% |
10,080
-773
| -7% | -$24.2K |
|
969
Maravai LifeSciences
MRVI
$376M
| $316K | ﹤0.01% |
49,850
+29,231
| +142% | +$185K |
|
970
Amicus Therapeutics
FOLD
$2.45B
| $307K | ﹤0.01% |
22,663
-2,103
| -8% | -$28.5K |
|
971
Ultragenyx Pharmaceutical
RARE
$3.02B
| $303K | ﹤0.01% |
6,325
+757
| +14% | +$36.3K |
|
972
HDFC Bank
HDB
$180B
| $301K | ﹤0.01% |
4,571
-370
| -7% | -$24.4K |
|
973
Sarepta Therapeutics
SRPT
$1.8B
| $291K | ﹤0.01% |
3,108
+1,227
| +65% | +$115K |
|
|
KAMN
974
DELISTED
Kaman Corp
KAMN
| $286K | ﹤0.01% |
12,444
-1,546
| -11% | -$35.6K |
|
975
Merus
MRUS
$5.08B
| $283K | ﹤0.01% |
10,114
-3,332
| -25% | -$93.4K |
|